Showing results (101-110 of 829) with videos related to
Sort By:
Pageof 83
Current Hypertension Reports|September 3, 2004
Remission and regression of diabetic nephropathyPeter Hovind, Lise Tarnow, Hans-Henrik ParvingCurrent Opinion in Nephrology and Hypertension|April 10, 2004
Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathyPeter Jacobsen, Kasper Rossing, Hans-Henrik ParvingJournal of Diabetes and Its Complications|May 4, 2015
Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetesBernt Johan von Scholten, Tine Willum Hansen, Jens Peter Goetze, et al.Cardiovascular Diabetology|March 7, 2012
NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patientsHenrik Reinhard, Peter R Hansen, Niels Wiinberg, et al.Journal of Translational Medicine|July 6, 2016
Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitusMichelle J Pena, Andreas Heinzel, Peter Rossing, et al.Journal of Diabetes and Its Complications|September 9, 2015
The influence of pharmaceutically induced weight changes on estimates of renal function: A patient-level pooled analysis of seven randomised controlled trials of glucose lowering medicationBernt Johan von Scholten, David Dynnes Ørsted, Anne Louise Svendsen, et al.Diabetes Care|June 22, 2019
Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without AlbuminuriaDorte Vistisen, Gregers Stig Andersen, Adam Hulman, et al.Ugeskrift for Laeger|August 25, 2020
[SGLT 2 inhibitors in Type 1 diabetes]Elisabeth Buur Stougaard, Hanan Amadid, Esben Søndergaard, et al.Journal of Diabetes and Its Complications|December 15, 2015
Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuriaBernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, et al.Diabetes Care|June 9, 2009
Tubular and glomerular injury in diabetes and the impact of ACE inhibitionStine E Nielsen, Takeshi Sugaya, Lise Tarnow, et al.Pageof 83